Filing Details
- Accession Number:
- 0000897069-24-000395
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-15 16:11:13
- Reporting Period:
- 2024-02-13
- Accepted Time:
- 2024-02-15 16:11:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1971532 | Telomir Pharmaceuticals Inc. | TELO | Pharmaceutical Preparations (2834) | 872606031 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1986593 | Trust Shore Bay | C/O Telomir Pharmaceuticals, Inc. 900 West Platt Street, Suite 200 Tampa FL 33606 | No | No | No | No | |
1996353 | Patrick Brian Mcnulty | C/O Telomir Pharmaceuticals, Inc. 900 West Platt Street, Suite 200 Tampa FL 33606 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-13 | 49,000 | $7.00 | 5,455,431 | No | 4 | P | Indirect | By Trust |
Common Stock | Acquisiton | 2024-02-13 | 40,000 | $7.00 | 1,365,646 | No | 4 | P | Indirect | See Footnote |
Common Stock | Acquisiton | 2024-02-13 | 49,000 | $7.00 | 1,902,659 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
No | 4 | P | Indirect | See Footnote |
No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 24,391 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (right to buy) | $3.73 | 2023-06-15 | 2028-06-15 | 2,439,025 | 2,439,025 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2028-06-15 | 2,439,025 | 2,439,025 | Indirect |
Footnotes
- These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- These securities are owned directly by the MIRALOGX, LLC, of which the Trust holds all of the membership interests, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.
- These securities are owned directly by Mr. McNulty.